(NYSE: LLY) Eli Lilly & Co's forecast annual revenue growth rate of 15.31% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.23%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.06%.
Eli Lilly & Co's revenue in 2026 is $72,249,500,000.On average, 33 Wall Street analysts forecast LLY's revenue for 2026 to be $79,740,070,070,238, with the lowest LLY revenue forecast at $73,385,199,062,550, and the highest LLY revenue forecast at $87,775,007,746,230. On average, 33 Wall Street analysts forecast LLY's revenue for 2027 to be $92,346,220,530,954, with the lowest LLY revenue forecast at $81,914,550,976,692, and the highest LLY revenue forecast at $106,032,548,384,352.
In 2028, LLY is forecast to generate $104,145,298,606,728 in revenue, with the lowest revenue forecast at $89,711,228,076,966 and the highest revenue forecast at $125,825,127,514,254.